Search

Your search keyword '"Bertaglia, E."' showing total 369 results
Start Over Author "Bertaglia, E."
369 results on '"Bertaglia, E."'

6. Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes

Author

Kirchhof, P., Toennis, T., Goette, A., Camm, A. J., Diener, H. C., Becher, N., Bertaglia, E., Blomqvist Lundqvist, C., Borlich, M., Brandes, A., Cabanelas, N., Calvert, M., Chlouverakis, G., Dan, G. -A, de Groot, J. R., Dichtl, W., Kravchuk, B., Lubinski, A., Marijon, E., Merkely, B., Mont, L., Ozga, A. -K, Rajappan, K., Sarkozy, A., Scherr, D., Sznajder, R., Velchev, V., Wichterle, D., Sehner, S., Simantirakis, E., Lip, G. Y. H., Vardas, P., Schotten, U., Zapf, A., Kirchhof, P., Toennis, T., Goette, A., Camm, A. J., Diener, H. C., Becher, N., Bertaglia, E., Blomqvist Lundqvist, C., Borlich, M., Brandes, A., Cabanelas, N., Calvert, M., Chlouverakis, G., Dan, G. -A, de Groot, J. R., Dichtl, W., Kravchuk, B., Lubinski, A., Marijon, E., Merkely, B., Mont, L., Ozga, A. -K, Rajappan, K., Sarkozy, A., Scherr, D., Sznajder, R., Velchev, V., Wichterle, D., Sehner, S., Simantirakis, E., Lip, G. Y. H., Vardas, P., Schotten, U., and Zapf, A.

Abstract

BACKGROUND Device-detected atrial high-rate episodes (AHREs) are atrial arrhythmias detected by implanted cardiac devices. AHREs resemble atrial fibrillation but are rare and brief. Whether the occurrence of AHREs in patients without atrial fibrillation (as documented on a conventional electrocardiogram [ECG]) justifies the initiation of anticoagulants is not known. METHODS We conducted an event-driven, double-blind, double-dummy, randomized trial involving patients 65 years of age or older who had AHREs lasting for at least 6 minutes and who had at least one additional risk factor for stroke. Patients were randomly assigned in a 1:1 ratio to receive edoxaban or placebo. The primary efficacy outcome was a composite of cardiovascular death, stroke, or systemic embolism, evaluated in a time-to-event analysis. The safety outcome was a composite of death from any cause or major bleeding. RESULTS The analysis population consisted of 2536 patients (1270 in the edoxaban group and 1266 in the placebo group). The mean age was 78 years, 37.4% were women, and the median duration of AHREs was 2.8 hours. The trial was terminated early, at a median follow-up of 21 months, on the basis of safety concerns and the results of an independent, informal assessment of futility for the efficacy of edoxaban; at termination, the planned enrollment had been completed. A primary efficacy outcome event occurred in 83 patients (3.2% per patient-year) in the edoxaban group and in 101 patients (4.0% per patient-year) in the placebo group (hazard ratio, 0.81; 95% confidence interval [CI], 0.60 to 1.08; P = 0.15). The incidence of stroke was approximately 1% per patient-year in both groups. A safety outcome event occurred in 149 patients (5.9% per patient-year) in the edoxaban group and in 114 patients (4.5% per patient-year) in the placebo group (hazard ratio, 1.31; 95% CI, 1.02 to 1.67; P = 0.03). ECG-diagnosed atrial fibrillation developed in 462 of 2536 patients (18.2% total, 8.7% per patient-y

Published
2023
Full Text
View/download PDF

9. 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Author

Zeppenfeld, K., Tfelt-Hansen, J., Riva, M. de, Winkel, B.G., Behr, E.R., Blom, N.A., Charron, P., Corrado, D., Dagres, N., Chillou, C. de, Eckardt, L., Friede, T., Haugaa, K.H., Hocini, M., Lambiase, P.D., Marijon, E., Merino, J.L., Peichl, P., Priori, S.G., Reichlin, T., Schulz-Menger, J., Sticherling, C., Tzeis, S., Verstrael, A., Volterrani, M., Cikes, M., Kirchhof, P., Abdelhamid, M., Aboyans, V., Arbelo, E., Arribas, F., Asteggiano, R., Basso, C., Bauer, A., Bertaglia, E., Biering-Sorensen, T., Blomstrom-Lundqvist, C., Borger, M.A., Celutkiene, J., Cosyns, B., Falk, V., Fauchier, L., Gorenek, B., Halvorsen, S., Hatala, R., Heidbuchel, H., Kaab, S., Konradi, A., Koskinas, K.C., Kotecha, D., Landmesser, U., Lewis, B.S., Linhart, A., Lochen, M.L., Lund, L.H., Metzner, A., Mindham, R., Nielsen, J.C., Norekval, T.M., Patten, M., Prescott, E., Rakisheva, A., Remme, C.A., Roca-Luque, I., Sarkozy, A., Scherr, D., Sitges, M., Touyz, R.M., Mieghem, N. van, Velagic, V., Viskin, S., Volders, P.G.A., Task Force Members, and ESC Scientific Document Group

Subjects
Genetic testing, Cardiac magnetic resonance, Sudden death, Ventricular tachycardia, Primary electrical disease, Guidelines, Recommendations, Chronic coronary artery disease, Risk calculator, Sudden cardiac death, Implantable cardioverter defibrillator, Ventricular arrhythmia, Catheter ablation, Anti-arrhythmic drugs, Ventricular fibrillation, Cardiomyopathies, Risk stratification, Premature ventricular complex
Published
2022

16. The Atrial Fibrillation Ablation Pilot Study: an European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association

Author

Arbelo, Elena, Brugada, Josep, Hindricks, Gerhard, Maggioni, Aldo P., Tavazzi, Luigi, Vardas, Panos, Laroche, Cécile, Anselme, Frédéric, Inama, Giuseppe, Jais, Pierre, Kalarus, Zbigniew, Kautzner, Josef, Lewalter, Thorsten, Mairesse, Georges H., Perez-Villacastin, Julian, Riahi, Sam, Taborsky, Milos, Theodorakis, George, Trines, Serge A., Brugada, Josep, Arbelo, Elena, Hindriks, Gerhard, Maggioni, Aldo P., Morgan, John, Tavazzi, Luigi, Vardas, Panos, Alonso, Angeles, Ferrari, Roberto, Komajda, Michel, Tavazzi, Luigi, Wood, David, Vardas, Panos, Brugada, Josep, Mairesse, Georges, Taborsky, Milos, Kautzner, Josef, Lewalter, Thorsten, Riahi, Sam, Jais, Pierre, Anselme, Frédéric, Theodorakis, George, Inama, Giuseppe, Trines, Serge, Kalarus, Zbigniew, Villacastin, Julian Perez, Maggioni, Aldo P., Manini, Malika, Gracia, Gérard, Laroche, Cécile, Missiamenou, Viviane, Taylor, Charles, Konte, Marème, Fiorucci, Emanuela, Lefrancq, Elin Folkesson, Glémot, Myriam, McNeill, Patti-Ann, Bois, Timothée, Heidbüchel, H., Nuyens, D., Boland, J., Dinraths, V., Herzet, J.-M., Hoffer, E., Malmendier, D., Massoz, M., Pourbaix, S., Ballant, E., Blommaert, D., Deceuninck, O., Dormal, F., Xhaet, O., De Potter, T., Geelen, P., Derycker, K., Duytschaever, M., Tavernier, R., Vandekerckhove, Y., Vankats, D., Bulava, A., Hanis, J., Sitek, D., Blahova, M., Cihak, R., Hanyasova, L., Jansova, H., Peichl, P., Tanzerova, M., Wichterle, D., Duda, J., Haman, L., Parizek, P., Coling, L., Neuzil, P., Petru, J., Sediva, L., Skoda, J., Chovancik, J., Fiala, M., Neuwirth, R., Karlsdottir, A., Pehrson, S., Gerdes, C., Jensen, H.K., Lukac, P., Nielsen, J. C., Hansen, J., Johannessen, A., Hansen, P. S., Pedersen, A.K., Heath, F.P., Hjortshoj, S., Thogersen, A.M., Da Costa, A., Martel, I., Romeyer-Bouchard, C., Sadki, N., Schmid, A., Haissaguerre, M., Hocini, M., Knecht, S., Sacher, F., Ait Said, M., Cauchemez, B., Ledoux, F., Thomas, O., Cebron, J.-P., Decarsin, N., Gras, D., Hervouet, S., Durand, C., Durand-Dubief, A., Poty, H., Babuty, D., Pierre, B., Albenque, J.-P., Boveda, S., Combes, N., Mas, R., Hermida, J-S., Kubala, M., Godin, B., Savouré, A., Soublin, Y., Defaye, P., Jacon, P., Brigadeau, F., Corbut, S., Flament-Balzola, F., Kacet, S., Klug, D., Lacroix, D., Copie, X., Gilles, L., Hocine, Z., Paziaud, O., Piot, O., Crocq, C., Kaballu, G., Le Moal, V., Lotton, P., Mabo, P., Pavin, D., Andronache, M., De Chillou, C., Magnin-Poull, I., Deharo, J.-C., Durand, C., Franceschi, F., Peyrouse, E., Prevot, S., Etchegoin, M., Extramiana, F., Leenhardt, A., Messali, A., Heine, T., Schneider, A., Winter, N., Brachmann, J., Ritscher, G., Schertel-Gruenler, B., Simon, H., Sinha, A.-M., Turschner, O., Wystrach, A., Stemberg, M., Kuck, K.-H., Metzner, A., Tilz, R., Wissner, E., Heitmann, K., Willems, S., Andresen, D., Mueller, S., Volkmer, M., Schmidt, B., Kostopoulou, A., Livanis, E., Voudris, V., Efremidis, M., Letsas, K., Tsikrikas, S., Christoforatou, E., Ioannidis, P., Katsivas, A., Kourouklis, S., Andrikopoulos, G., Rassias, I., Tzeis, S., Dakos, G., Paraskevaidis, S., Stavropoulos, G., Theofilogiannakos, E., Vassilikos, V.P., Bongiorni, M.G., Zucchelli, G., Raviele, A., Themistoclakis, S., Pratola, C., Tritto, M., Della Bella, P., Mazzone, P., Moltrasio, M., Tondo, C., Calo, L., De Luca, L., Guarracini, F., Lioy, E., Dozza, L., Frigoli, E., Giannelli, L., Pappone, C., Saviano, M., Schiavina, G., Vicedomini, G.G., De Ponti, R., Doni, L. A., Marazzi, R., Salerno-Uriarte, J.A., Tamborini, C., Anselmino, M., Ferraris, F., Gaita, F., Bertaglia, E., Brandolino, G., Zoppo, F., De Groot, N., Janse, P., Jordaens, L., Pison, L., Roos, C., Van Gelder, I., Manusama, R., Meijer, A., Van der Voort, P., Trines, S., Compier, Marieke G., Kazmierczak, J., Kornacewicz-Jach, Z., Wielusinski, M., Baran, J., Kulakowski, P., Dzidowski, M., Fuglewicz, A., Nowak, K., Pruszkowska-Skrzep, P., Wozniak, A., Nowak, S., Trusz-Gluza, M., Almendral, J., Atienza, F., Castellanos, E., De Diego, C., Ortiz, M., Moreno Planas, J., Perez Castellano, N., Benezet, J., Farre Muncharaz, J., Rubio Campal, J.M., Hernandez Madrid, A., Matia, R., Arana, E., Pedrote, A., Cozar, R., Peinado, R., Valverde, I., Arbelo, E., Berruezo, A., Calvo, N., Guiu, E., Husseini, S., and Mont Girbau, L.

Published
2014
Full Text
View/download PDF

18. The subcutaneous implantable cardioverter-defibrillator in clinical practice

Author

Migliore F., Mattesi G., Zorzi A., Viani S., Bongiorni M. G., Francia P., Curcio A., Diemberger I., Bertaglia E., Migliore F., Mattesi G., Zorzi A., Viani S., Bongiorni M.G., Francia P., Curcio A., Diemberger I., and Bertaglia E.

Subjects
Subcutaneous implantable cardioverter-defibrillator, Sudden cardiac death, Death, Sudden, Cardiac, Patient Selection, Electric Countershock, Humans, Arrhythmias, Cardiac, Defibrillators, Implantable
Abstract

Overcoming lead-related complications, the subcutaneous implantable cardioverter-defibrillator (S-ICD) represents the greatest advancement in the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Due to the absence of leads within the body, the S-ICD requires an innovative approach for sensing of subcutaneous signals and defibrillation. The aim of this review is to analyze the current evidence regarding patient selection, technical aspects such as the implant technique, programming and follow-up, as well as complications and troubleshooting of this innovative technology.

Published
2019

19. Clinical discussions in antithrombotic therapy management : a delphi consensus panel

Author

De Angelis G, Camerini A, Marra S, Racani C, Marchetti G, Serrati C, Bertaglia E, Filippucci L, and Maggi A

Subjects
medicine.medical_specialty, business.industry, MEDLINE, Atrial fibrillation, medicine.disease, Clinical trial, Therapy management, Therapy compliance, Antithrombotic, Medicine, Cardiology and Cardiovascular Medicine, business, Intensive care medicine, computer, Venous thromboembolism, Delphi, Original Research, computer.programming_language
Abstract

For some years now, direct-acting oral anticoagulants (DOACs) have entered the clinical practice for stroke prevention in non-valvular atrial fibrillation (NVAF) or prevention and treatment of venous thromboembolism (VTE). However, there is uncertainty on DOAC use in some clinical scenarios not fully explored by clinical trials, but commonly encountered in the real world. We report a Delphi Consensus on DOAC use in NVAF and VTE patients. The consensus dealt with 16 main topics: (1) clinical superiority of DOACs compared to VKAs; (2) DOACs as a first-line treatment in patients with AF; (3) therapeutic options for patients undergoing electrical cardioversion; (4) selection of patients suitable for switching from VKAs to DOACs; (5) and (7) role of general practitioners in the follow-up of patients receiving a DOAC; (6) duties of Italian oral anticoagulation therapy centers; (8) role of therapy with DOACs in oncological patients with NVAF; (9) role of DOACs in oncological patients with VTE; (10) methods for administration and therapy compliance for DOACs; (11) drug interactions; (12) safety of low doses of DOACs; (13) therapeutic management of frail patients with NVAF; (14) therapeutic management of NVAF patients with glomerular filtration rate

Published
2020
Full Text
View/download PDF

20. Impact of ablation index settings on pulmonary vein reconnection

Author

Lepillier, A., primary, Strisciuglio, T., additional, De Ruvo, E., additional, Scaglione, M., additional, Anselmino, M., additional, Sebag, F. A., additional, Pecora, D., additional, Gallagher, M. M., additional, Rillo, M., additional, Viola, G., additional, Pisanò, E., additional, Abbey, S., additional, Lamberti, F., additional, Pani, A., additional, Zucchelli, G., additional, Sgarito, G., additional, De Simone, A., additional, Bertaglia, E., additional, Solimene, F., additional, and Stabile, Giuseppe, additional

Published
2021
Full Text
View/download PDF

22. Cardiac resynchronization therapy by multipoint pacing improves response of left ventricular mechanics and fluid dynamics: A three-dimensional and particle image velocimetry echo study

Author

Siciliano, M, Migliore, F, Badano, L, Bertaglia, E, Pedrizzetti, G, Cavedon, S, Zorzi, A, Corrado, D, Iliceto, S, Muraru, D, Siciliano M., Migliore F., Badano L., Bertaglia E., Pedrizzetti G., Cavedon S., Zorzi A., Corrado D., Iliceto S., Muraru D., Siciliano, M, Migliore, F, Badano, L, Bertaglia, E, Pedrizzetti, G, Cavedon, S, Zorzi, A, Corrado, D, Iliceto, S, Muraru, D, Siciliano M., Migliore F., Badano L., Bertaglia E., Pedrizzetti G., Cavedon S., Zorzi A., Corrado D., Iliceto S., and Muraru D.

Abstract

Conventional biventricular pacing (BiV) involves pacing from the right ventricle (RV), and the left ventricle (LV) usually using a single bipolar lead at one site via the coronary sinus (CS), with the aimto restore electrical and mechanical synchrony in heart failure (HF) patients.1 However, one-third of patients fail to clinically respond to cardiac resyncronization therapy (CRT), which may be partially due to a suboptimal location of the LV lead position with persistent LV dyssynchrony.2 In search for improvements in CRT, several authors have proposed a multisite LV stimulation using multiple leads in different branches of the CS.3 However, this technique is associated with increased procedure duration, fluoroscopy exposure, and potential complications. A new approach that involves a multisite pacing performed within a single CS branch by using a single quadripolar lead (multipoint pacing, or MPP; St. Jude Medical, Sylmar, CA) has been suggested recently. Benefits in acute haemodynamics using pressure-volume loop analysis and LV dyssynchrony using two dimensional echocardiographic (2DE) have been demonstrated with MPP in comparison with BiV.4-7 Nevertheless, the effects of MPP on LV dyssynchrony using three-dimensional echocardiography (3DE) and on diastolic filling have not been established yet. Echocardiographic particle imaging velocimetry (Echo-PIV) is an emerging imaging technique, which allows intraventricular fluid dynamics blood assessment and characterization of diastolic vortex formation that may play a key role in LV filling efficiency.8-12 Recent fluid dynamics data demonstrated that in normal LV, the blood flow is characterized by a longitudinal alignment along the base-apex direction of the intraventricular hemodynamic fluid dynamics in compliance with the empting-filling process.12 Conversely, HF patients show an irregular vortex formation with local stagnation resulting in transversal forces and loss of the physiological longitudinal orientation of

Published
2017

23. Italian Ablation Register 2017. Italian Association of Arrhythmology and Cardiostimulation

Author

Stabile, G., Bertaglia, E., Guerra, F., Palmisano, P., Berisso, M. Z., Soldati, E., Bisignani, G., Forleo, G. B., Zanotto, G., Landolina, M., De Ponti, R., Boriani, G., and Ricci, R. P.

Subjects
Registry, Italy, Medical, Arrhythmias, Catheter ablation, Arrhythmias, Cardiac, Cardiology, Catheter Ablation, Electrophysiologic Techniques, Cardiac, Humans, Retrospective Studies, Societies, Medical, Registries, Electrophysiologic Techniques, Societies, Cardiac
Published
2019

29. Long term follow up of radiofrequency catheter ablation of atrial flutter: clinical course and predictors of atrial fibrillation occurrence

Author

Bertaglia, E., Zoppo, F., Bonso, A., Proclemer, A., Verlato, R., Coro, L., Mantovan, R., D'Este, D., Zerbo, F., and Pascotto, P.

Subjects
Health
Abstract

Heart 2004;90:59-63 Objectives: To evaluate the time to onset and the predictors of atrial fibrillation (AF) during long term follow up of patients with typical atrial flutter (AFL) treated with [...]

Published
2003

30. P5688Is renal dysfunction associated with the outcome of CRT patients?

Author

Bertaglia, E, primary, Reggiani, A, additional, Palmisano, P, additional, D'Onofrio, A, additional, De Simone, A, additional, Caico, S, additional, Pecora, D, additional, Arena, G, additional, Ricciardi, G, additional, Marini, M, additional, Rapacciuolo, A, additional, Parisi, Q, additional, Maglia, G, additional, Malacrida, M, additional, and Stabile, G, additional

Published
2019
Full Text
View/download PDF

31. 3290The VALID-CRT risk score reliably predicts outcome after cardiac resynchronization therapy in an real-world population

Author

Pecora, D, primary, Reggiani, A, additional, Palmisano, P, additional, Badolati, S, additional, Parisi, Q, additional, Savarese, G, additional, Maglia, G, additional, Giovannini, T, additional, Ferraro, A, additional, Spotti, A, additional, Solimene, F, additional, La Greca, C, additional, Malacrida, M, additional, Stabile, G, additional, and Bertaglia, E, additional

Published
2018
Full Text
View/download PDF

32. P1944Cardiac resynchronization therapy in elderly: Predictors of mortality at 12-months follow-up

Author

Pecora, D, primary, Pepi, P, additional, Palmisano, P, additional, D'Onofrio, A, additional, De Simone, A, additional, Caico, S, additional, Rapacciuolo, A, additional, Arena, G, additional, Marini, M, additional, Ricciardi, G, additional, Migliore, F, additional, La Greca, C, additional, Malacrida, M, additional, Stabile, S, additional, and Bertaglia, E, additional

Published
2018
Full Text
View/download PDF

34. 267The VALID-CRT risk score reliably predicts outcome after cardiac resynchronization therapy in an real-world population

Author

Bertaglia, E, primary, Reggiani, A, additional, Palmisano, P, additional, Badolati, S, additional, Parisi, Q, additional, Savarese, G, additional, Maglia, G, additional, Giovannini, T, additional, Ferraro, A, additional, Spotti, A, additional, Solimene, F, additional, Baritussio, A, additional, Cecchetto, A, additional, Malacrida, M, additional, and Stabile, G, additional

Published
2018
Full Text
View/download PDF

36. P330Cardiac resynchronization therapy in elderly: predictors of mortality at 12-months follow-up

Author

Bertaglia, E, primary, Pepi, P, additional, Palmisano, P, additional, D'onofrio, A, additional, De Simone, A, additional, Caico, S, additional, Pecora, D, additional, Rapacciuolo, A, additional, Arena, G, additional, Marini, M, additional, Ricciardi, G, additional, Migliore, F, additional, Ferretto, S, additional, Malacrida, M, additional, and Stabile, G, additional

Published
2018
Full Text
View/download PDF

39. Transthoracic 3D echocardiography imaging of transcatheter pacing system

Author

Muraru, D, Migliore, F, Cipriani, A, Iliceto, S, Bertaglia, E, MURARU, DENISA, MIGLIORE, FEDERICO, CIPRIANI, ALBERTO, ILICETO, SABINO, BERTAGLIA, EMANUELE, Muraru, D, Migliore, F, Cipriani, A, Iliceto, S, Bertaglia, E, MURARU, DENISA, MIGLIORE, FEDERICO, CIPRIANI, ALBERTO, ILICETO, SABINO, and BERTAGLIA, EMANUELE

Published
2017

43. Valsartan for prevention of recurrent atrial fibrillation

Author

GISSI AF Investigators, Disertori M, Latini R, Barlera S, Franzosi MG, Staszewsky L, Maggioni AP, Lucci D, Di Pasquale G, Tognoni G, Delise P, Bertocchi F, Maiocchi G, Geraci E, Correale E, Lombardi F, Mugelli A, Urso R, Scardi S, Fabbri G, Bartolomei B, Barbato G, Carbonieri E, Ciricugno S, Cosmi F, Pratola C, Rossi MG, Sciarra L, Zeni P, Ceseri M, Atzori A, Bambi F, Baviera M, Bianchini F, Fenicia E, Gianfriddo M, Lonardo G, Luise A, Nota R, Orlando ME, Petrolo R, Pierattini C, Pierota V, Ragno A, Serio C, Tafi A, Tellaroli E, Masson S, Vago T, Gramenzi S, Orso F, Suliman I, Nicolis E, Casola C, Dall'Osso D, Gorini M, Bianchini E, Cabiddu S, Cangioli I, Carnaghi A, Cipressa ML, Cipressa L, Galbiati L, Lorimer A, Priami P, Moccetti T, Vaghi F, Capello AF, Rossetti G, Viada E, Morena L, Delucchi M, Reynaud SG, Allemano P, Massobrio N, Gavazzi A, Taddei F, Mor DA, Bortolini F, Lorini M, Inama G, Durin O, Pirelli S, Spotti A, Procopio R, Cuzzucrea D, Gentile G, Margonato A, Bassanelli G, Tavazzi L, Buzzi MP, Rordorf R, Gualco A, Opasich C, Gronda E, Genovese L, Mattioli R, Donatelli F, Uriarte JA, Rauhe W, Bertagnolli C, Canestrini S, Stefenelli C, Cioffi G, Giovanelli C, Rigatelli G, Boni S, Pasini A, Sitta N, Sacchetta A, Borgese L, Sciascia R, Targa L, Raviele A, Madalosso M, Bertaglia E, Zoppo FC, Capanna M, Fiorencis R, Baracca E, Rossi R, Rossi I, Trappolin R, Morgera T, Barducci E, Baldin MG, Gobbo G, Zardo F, Hrovatin E, Mos L, Vriz O, Sinagra G, Aleksova A, Mazzone C, Fresco C, Rubartelli P, Moroni LA, Camerieri A, Piana M, Mureddu R, Bertoli D, Petacchi R, Pancaldi LG, Gabrieli L, Urbinati S, Pedone C, Di Niro M, Brunelli A, Bosi S, Censi S, Moruzzi P, Pastori P, Modena MG, Malavasi V, Mezzetti M, Melandri F, Zuppiroli A, Fazi A, Testa R, Venturini E, Mazzinghi F, Cosmi D, Santoro GM, Minneci C, Galli M, Paperini L, Bovenzi FM, Cortigiani L, Cocchieri M, Severini D, Arcuri GM, Bagliani G, Bernardinangeli M, Proietti G, Bocconcelli P, Pierantozzi A, Monti F, Giamundo L, Tancredi P, Rossini E, Bianchi C, Bettiol F, Giovannini E, Fera MS, Santini M, Bianconi L, Boccanelli A, Morosetti P, Volpe M, Facciolo C, Vacri A, Romanazzi F, Napoletano C, Piccioni LL, Candelmo F, De Marco G, Arnese MR, Vetrano A, Prinzi D, De Rosa P, Capuano V, Torre S, D'Onofrio A, Ammendola E, Battista R, De Fusco A, Molero U, Iervoglini A, Stefanelli S, Fattore L, Bosco B, Liguori A, Padula G, De Luca I, Sorino M, Colonna P, D'Agostino C, Pierfelice O, Pettinati G, Muscella A, De Lorenzi E, Falco M, Giannattasio C, Baldi N, Clemente MA, D'Alessandro B, Truncellito L, Arabia F, Ciconte VA, Perticone F, Ruberto C, Buffon A, Tomaselli C, De Rosa F, Mazza S, Zampaglione G, Pirozzi AM, Butera A, Levato M, Musacchio D, Polimeni RM, Lacquaniti V, Pulitanò G, Ruggeri A, Provenzano A, Cuccurullo O, Musolino M, Marrari A, Anastasio L, Schiavello M, Comito MG, Gulizia MM, Francese GM, Vasquez L, Coppolino C, Casale A, D'Urso G, Oliva G, Giordano U, Andolina S, Sanfilippo N, Ingrillì F, Accardo S, Grasso S, Buffa L, Serra E., CHIARIELLO, MASSIMO, PERRONE FILARDI, PASQUALE, Delise, P., Bertocchi, F., Maiocchi, G., Geraci, E., Correale, E., Lombardi, F., Mugelli, A., Urso, R., Scardi, S., Fabbri, G., Bartolomei, B., Barbato, G., Carbonieri, E., Ciricugno, S., Cosmi, F., Pratola, C., Rossi, M. G., Sciarra, L., Zeni, P., Ceseri, M., Atzori, A., Bambi, F., Baviera, M., Bianchini, F., Fenicia, E., Gianfriddo, M., Lonardo, G., Luise, A., Nota, R., Orlando, M. E., Petrolo, R., Pierattini, C., Pierota, V., Ragno, A., Serio, C., Tafi, A., Tellaroli, E., Masson, S., Vago, T., Gramenzi, S., Orso, F., Suliman, I., Nicolis, E., Casola, C., Dall'Osso, D., Gorini, M., Bianchini, E., Cabiddu, S., Cangioli, I., Carnaghi, A., Cipressa, M. L., Cipressa, L., Galbiati, L., Lorimer, A., Priami, P., Moccetti, T., Vaghi, F., Capello, A. F., Rossetti, G., Viada, E., Morena, L., Delucchi, M., Reynaud, S. G., Allemano, P., Massobrio, N., Gavazzi, A., Taddei, F., Mor, D. A., Bortolini, F., Lorini, M., Inama, G., Durin, O., Pirelli, S., Spotti, A., Procopio, R., Cuzzucrea, D., Gentile, G., Margonato, A., Bassanelli, G., Tavazzi, L., Buzzi, M. P., Rordorf, R., Gualco, A., Opasich, C., Gronda, E., Genovese, L., Mattioli, R., Donatelli, F., Uriarte, J. A., Rauhe, W., Bertagnolli, C., Canestrini, S., Stefenelli, C., Cioffi, G., Giovanelli, C., Rigatelli, G., Boni, S., Pasini, A., Sitta, N., Sacchetta, A., Borgese, L., Sciascia, R., Targa, L., Raviele, A., Madalosso, M., Bertaglia, E., Zoppo, F. C., Capanna, M., Fiorencis, R., Baracca, E., Rossi, R., Rossi, I., Trappolin, R., Morgera, T., Barducci, E., Baldin, M. G., Gobbo, G., Zardo, F., Hrovatin, E., Mos, L., Vriz, O., Sinagra, G., Aleksova, A., Mazzone, C., Fresco, C., Rubartelli, P., Moroni, L. A., Camerieri, A., Piana, M., Mureddu, R., Bertoli, D., Petacchi, R., Pancaldi, L. G., Gabrieli, L., Urbinati, S., Pedone, C., Di Niro, M., Brunelli, A., Bosi, S., Censi, S., Moruzzi, P., Pastori, P., Modena, M. G., Malavasi, V., Mezzetti, M., Melandri, F., Zuppiroli, A., Fazi, A., Testa, R., Venturini, E., Mazzinghi, F., Cosmi, D., Santoro, G. M., Minneci, C., Galli, M., Paperini, L., Bovenzi, F. M., Cortigiani, L., Cocchieri, M., Severini, D., Arcuri, G. M., Bagliani, G., Bernardinangeli, M., Proietti, G., Bocconcelli, P., Pierantozzi, A., Monti, F., Giamundo, L., Tancredi, P., Rossini, E., Bianchi, C., Bettiol, F., Giovannini, E., Fera, M. S., Santini, M., Bianconi, L., Boccanelli, A., Morosetti, P., Volpe, M., Facciolo, C., Vacri, A., Romanazzi, F., Napoletano, C., Piccioni, L. L., Candelmo, F., De Marco, G., Arnese, M. R., Vetrano, A., Prinzi, D., De Rosa, P., Capuano, V., Torre, S., D'Onofrio, A., Ammendola, E., Chiariello, M., Filardi, Pp., Battista, R., De Fusco, A., Molero, U., Iervoglini, A., Stefanelli, S., Fattore, L., Bosco, B., Liguori, A., Padula, G., De Luca, I., Sorino, M., Colonna, P., D'Agostino, C., Pierfelice, O., Pettinati, G., Muscella, A., De Lorenzi, E., Falco, M., Giannattasio, C., Baldi, N., Clemente, M. A., D'Alessandro, B., Truncellito, L., Arabia, F., Ciconte, V. A., Perticone, F., Ruberto, C., Buffon, A., Tomaselli, C., De Rosa, F., Mazza, S., Zampaglione, G., Pirozzi, A. M., Butera, A., Levato, M., Musacchio, D., Polimeni, R. M., Lacquaniti, V., Pulitano, G., Ruggeri, A., Provenzano, A., Cuccurullo, O., Musolino, M., Marrari, A., Anastasio, L., Schiavello, M., Comito, M. G., Gulizia, M. M., Francese, G. M., Vasquez, L., Coppolino, C., Casale, A., D'Urso, G., Oliva, G., Giordano, U., Andolina, S., Sanfilippo, N., Ingrilli, F., Accardo, S., Grasso, S., Buffa, L., Serra, E., Disertori, Marcello, Latini, Roberto, Barlera, Simona, Franzosi, Maria Grazia, Staszewsky, Lidia, Maggioni, Aldo Pietro, Lucci, Donata, Di Pasquale, Giuseppe, Tognoni, Gianni, GISSI AF, Investigator, Disertori, M, Latini, R, Barlera, S, Franzosi, Mg, Staszewsky, L, Maggioni, Ap, Lucci, D, Di Pasquale, G, Tognoni, G, Delise, P, Bertocchi, F, Maiocchi, G, Geraci, E, Correale, E, Lombardi, F, Mugelli, A, Urso, R, Scardi, S, Fabbri, G, Bartolomei, B, Barbato, G, Carbonieri, E, Ciricugno, S, Cosmi, F, Pratola, C, Rossi, Mg, Sciarra, L, Zeni, P, Ceseri, M, Atzori, A, Bambi, F, Baviera, M, Bianchini, F, Fenicia, E, Gianfriddo, M, Lonardo, G, Luise, A, Nota, R, Orlando, Me, Petrolo, R, Pierattini, C, Pierota, V, Ragno, A, Serio, C, Tafi, A, Tellaroli, E, Masson, S, Vago, T, Gramenzi, S, Orso, F, Suliman, I, Nicolis, E, Casola, C, Dall'Osso, D, Gorini, M, Bianchini, E, Cabiddu, S, Cangioli, I, Carnaghi, A, Cipressa, Ml, Cipressa, L, Galbiati, L, Lorimer, A, Priami, P, Moccetti, T, Vaghi, F, Capello, Af, Rossetti, G, Viada, E, Morena, L, Delucchi, M, Reynaud, Sg, Allemano, P, Massobrio, N, Gavazzi, A, Taddei, F, Mor, Da, Bortolini, F, Lorini, M, Inama, G, Durin, O, Pirelli, S, Spotti, A, Procopio, R, Cuzzucrea, D, Gentile, G, Margonato, A, Bassanelli, G, Tavazzi, L, Buzzi, Mp, Rordorf, R, Gualco, A, Opasich, C, Gronda, E, Genovese, L, Mattioli, R, Donatelli, F, Uriarte, Ja, Rauhe, W, Bertagnolli, C, Canestrini, S, Stefenelli, C, Cioffi, G, Giovanelli, C, Rigatelli, G, Boni, S, Pasini, A, Sitta, N, Sacchetta, A, Borgese, L, Sciascia, R, Targa, L, Raviele, A, Madalosso, M, Bertaglia, E, Zoppo, Fc, Capanna, M, Fiorencis, R, Baracca, E, Rossi, R, Rossi, I, Trappolin, R, Morgera, T, Barducci, E, Baldin, Mg, Gobbo, G, Zardo, F, Hrovatin, E, Mos, L, Vriz, O, Sinagra, G, Aleksova, A, Mazzone, C, Fresco, C, Rubartelli, P, Moroni, La, Camerieri, A, Piana, M, Mureddu, R, Bertoli, D, Petacchi, R, Pancaldi, Lg, Gabrieli, L, Urbinati, S, Pedone, C, Di Niro, M, Brunelli, A, Bosi, S, Censi, S, Moruzzi, P, Pastori, P, Modena, Mg, Malavasi, V, Mezzetti, M, Melandri, F, Zuppiroli, A, Fazi, A, Testa, R, Venturini, E, Mazzinghi, F, Cosmi, D, Santoro, Gm, Minneci, C, Galli, M, Paperini, L, Bovenzi, Fm, Cortigiani, L, Cocchieri, M, Severini, D, Arcuri, Gm, Bagliani, G, Bernardinangeli, M, Proietti, G, Bocconcelli, P, Pierantozzi, A, Monti, F, Giamundo, L, Tancredi, P, Rossini, E, Bianchi, C, Bettiol, F, Giovannini, E, Fera, M, Santini, M, Bianconi, L, Boccanelli, A, Morosetti, P, Volpe, M, Facciolo, C, Vacri, A, Romanazzi, F, Napoletano, C, Piccioni, Ll, Candelmo, F, De Marco, G, Arnese, Mr, Vetrano, A, Prinzi, D, De Rosa, P, Capuano, V, Torre, S, D'Onofrio, A, Ammendola, E, Chiariello, Massimo, PERRONE FILARDI, Pasquale, Battista, R, De Fusco, A, Molero, U, Iervoglini, A, Stefanelli, S, Fattore, L, Bosco, B, Liguori, A, Padula, G, De Luca, I, Sorino, M, Colonna, P, D'Agostino, C, Pierfelice, O, Pettinati, G, Muscella, A, De Lorenzi, E, Falco, M, Giannattasio, C, Baldi, N, Clemente, Ma, D'Alessandro, B, Truncellito, L, Arabia, F, Ciconte, Va, Perticone, F, Ruberto, C, Buffon, A, Tomaselli, C, De Rosa, F, Mazza, S, Zampaglione, G, Pirozzi, Am, Butera, A, Levato, M, Musacchio, D, Polimeni, Rm, Lacquaniti, V, Pulitanò, G, Ruggeri, A, Provenzano, A, Cuccurullo, O, Musolino, M, Marrari, A, Anastasio, L, Schiavello, M, Comito, Mg, Gulizia, Mm, Francese, Gm, Vasquez, L, Coppolino, C, Casale, A, D'Urso, G, Oliva, G, Giordano, U, Andolina, S, Sanfilippo, N, Ingrillì, F, Accardo, S, Grasso, S, and Buffa, L

Subjects
Male, medicine.medical_specialty, medicine.medical_treatment, Tetrazoles, Cardiomegaly, Comorbidity, Placebo, Cardioversion, Double-Blind Method, Recurrence, Multicenter trial, Internal medicine, Angiotensin II Type 1 Receptor Blocker, Cardiovascular Disease, Atrial Fibrillation, medicine, Left atrial enlargement, Diabetes Mellitus, Humans, Sinus rhythm, cardiovascular diseases, Prospective Studies, Tetrazole, Proportional Hazards Models, Aged, business.industry, Medicine (all), Hazard ratio, Atrial fibrillation, Diabetes Mellitu, Valine, General Medicine, Middle Aged, medicine.disease, valsartan, atrial fibrillation, Prospective Studie, Valsartan, Cardiovascular Diseases, cardiovascular system, Cardiology, Proportional Hazards Model, Female, business, Angiotensin II Type 1 Receptor Blockers, medicine.drug, Human
Abstract

BACKGROUND: Atrial fibrillation is the most common cardiac arrhythmia, and no current therapy is ideal for control of this condition. Experimental studies suggest that angiotensin II-receptor blockers (ARBs) can influence atrial remodeling, and some clinical studies suggest that they may prevent atrial fibrillation. METHODS: We conducted a large, randomized, prospective, placebo-controlled, multicenter trial to test whether the ARB valsartan could reduce the recurrence of atrial fibrillation. We enrolled patients who were in sinus rhythm but had had either two or more documented episodes of atrial fibrillation in the previous 6 months or successful cardioversion for atrial fibrillation in the previous 2 weeks. To be eligible, patients also had to have underlying cardiovascular disease, diabetes, or left atrial enlargement. Patients were randomly assigned to receive valsartan or placebo. The two primary end points were the time to a first recurrence of atrial fibrillation and the proportion of patients who had more than one recurrence of atrial fibrillation over the course of 1 year. RESULTS: A total of 1442 patients were enrolled in the study. Atrial fibrillation recurred in 371 of the 722 patients (51.4%) in the valsartan group, as compared with 375 of 720 (52.1%) in the placebo group (adjusted hazard ratio, 0.97; 96% confidence interval [CI], 0.83 to 1.14; P = 0.73). More than one episode of atrial fibrillation occurred in 194 of 722 patients (26.9%) in the valsartan group and in 201 of 720 (27.9%) in the placebo group (adjusted odds ratio, 0.89; 99% CI, 0.64 to 1.23; P = 0.34). The results were similar in all predefined subgroups of patients, including those who were not receiving angiotensin-converting-enzyme inhibitors. CONCLUSIONS: Treatment with valsartan was not associated with a reduction in the incidence of recurrent atrial fibrillation. (ClinicalTrials.gov number, NCT00376272.) Copyright © 2009 Massachusetts Medical Society.

Published
2009

44. P5486Predictors of mortality in CRT patients: results from a large real-world population

Author

Botto, G.L., primary, Palmisano, P., additional, Pepi, P., additional, D'Onofrio, A., additional, Marini, M., additional, De Simone, A., additional, Caico, S.I., additional, Pecora, D., additional, Santamaria, M., additional, Arena, G., additional, Pieragnoli, P., additional, Savarese, G., additional, Bertaglia, E., additional, Malacrida, M., additional, and Stabile, G., additional

Published
2017
Full Text
View/download PDF

45. P5509The use of three-dimensional echocardiography to measure left ventricular ejection fraction would increase the number of patients with indication to receive implantable cardioverter defibrillators

Author

Rodriguez Zanella, H., primary, Boccalini, F., additional, Secco, E., additional, Muraru, D., additional, Aruta, P., additional, Bertaglia, E., additional, Arias-Godinez, J.A., additional, Alexanderson, E., additional, Marroquin Donday, L.A., additional, Iliceto, S., additional, and Badano, L.P., additional

Published
2017
Full Text
View/download PDF

46. P5484Adherence to ESC guidelines class I was associated to better prognosis, clinical response and LV reverse remodeling in a large real-world CRT population

Author

Botto, G.L., primary, Bertaglia, E., additional, Pecora, D., additional, Rapacciuolo, A., additional, Reggiani, A., additional, Marenna, B., additional, Marini, M., additional, Ferraro, A., additional, Maglia, G., additional, Badolati, S., additional, Spotti, A., additional, Ricciardi, G., additional, Amadori, F., additional, Malacrida, M., additional, and Stabile, G., additional

Published
2017
Full Text
View/download PDF

47. P1511Electrocardiographic parameters during LV- and RV- pacing predict super-response in cardiac resynchronization therapy

Author

Marini, M., primary, Pecora, D., additional, De Simone, A., additional, Parisi, Q., additional, Bertaglia, E., additional, Palmisano, P., additional, Coser, A., additional, Viscusi, M., additional, Spotti, A., additional, Canciello, M., additional, Pani, A., additional, Badolati, S., additional, Giovannini, T., additional, Malacrida, M., additional, and Stabile, G., additional

Published
2017
Full Text
View/download PDF

48. P1009Predictors of mortality in CRT patients: results from a large real-world population

Author

Botto, GL., primary, Palmisano, P., additional, Pepi, P., additional, D'onofrio, A., additional, Guarracini, F., additional, De Simone, A., additional, Caico, SI., additional, Pecora, D., additional, Santamaria, M., additional, Arena, G., additional, Pieragnoli, P., additional, Savarese, G., additional, Bertaglia, E., additional, Malacrida, M., additional, and Stabile, G., additional

Published
2017
Full Text
View/download PDF

49. 184Adherence to ESC guidelines class I was associated to better prognosis, clinical response and LV reverse remodeling in a large real-world CRT population

Author

Ferraro, A., primary, Bertaglia, E., additional, Botto, GL., additional, Rapacciuolo, A., additional, Reggiani, A., additional, Marenna, B., additional, Marini, M., additional, Mazza, A., additional, Maglia, G., additional, Badolati, S., additional, Spotti, A., additional, Ricciardi, G., additional, Amadori, F., additional, Malacrida, M., additional, and Stabile, G., additional

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results